Napabucasin 5mg | ≥99%
CSNpharm
Napabucasin is a first-in-class cancer stemness inhibitor that targets STAT3.
More Information Supplier Page
Napabucasin is a first-in-class cancer stemness inhibitor that targets STAT3.
More Information Supplier Page
Dinaciclib is a potent CDK inhibitor for CDK2, CDK5, CDK1 and CDK9 with IC50 of 1 nM, 1 nM, 3 nM and 4 nM, respectively.
More Information Supplier Page
CID-16020046 is a selective GPR55 (LPI receptor) antagonist with IC50 of 0.15 μM.
More Information Supplier Page
CID-16020046 is a selective GPR55 (LPI receptor) antagonist with IC50 of 0.15 μM.
More Information Supplier Page
Emodin shows antiproliferative effects in cancer cells that are regulated by different signaling pathways, it is a naturally occurring anthraquinone present in the roots and barks of numerous plants.
More Information Supplier Page
Emodin shows antiproliferative effects in cancer cells that are regulated by different signaling pathways, it is a naturally occurring anthraquinone present in the roots and barks of numerous plants.
More Information Supplier Page
cGAMP, an endogenous second messenger, can induce the formation of cytokines and promote innate immune response. It also acts as an activator of STING with antitumor activity.
More Information Supplier Page
cGAMP, an endogenous second messenger, can induce the formation of cytokines and promote innate immune response. It also acts as an activator of STING with antitumor activity.
More Information Supplier Page
CID-16020046 is a selective GPR55 (LPI receptor) antagonist with IC50 of 0.15 μM.
More Information Supplier Page
CID-16020046 is a selective GPR55 (LPI receptor) antagonist with IC50 of 0.15 μM.
More Information Supplier Page